The Pediatric Neurology market is witnessing substantial growth as a result of increasing awareness, early diagnosis, and advancements in pediatric neurological care. The market encompasses a spectrum of disorders, including epilepsy, neurogenetic disorders, and developmental delays in children. Rising instances of pediatric neurological conditions, coupled with a growing emphasis on specialized healthcare for children, drive market expansion. Technological innovations in diagnostic tools and treatment modalities contribute to improved patient outcomes. Additionally, collaborative efforts between healthcare providers, researchers, and pharmaceutical companies foster research and development in pediatric neurology. Geographically, North America and Europe dominate the market, given their robust healthcare infrastructures. However, the Asia-Pacific region is experiencing notable growth, attributed to increasing healthcare investments and a rising prevalence of pediatric neurological disorders. The market is characterized by ongoing research initiatives, with a focus on developing targeted therapies tailored to the unique needs of pediatric patients.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
